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ABSTRACT 
 
Patterns of Drug Used In Osteoarthritis Patient 
( Study at Orthopaedic Clinic of RSUD Dr. Soetomo Surabaya ) 
 
Siti Nor Fariqian Afifa Ridzuan 
 
Osteoarthritis (OA) is characterized by degeneration of 
articular cartilage, limited intraarticular inflammation with synovitis, 
and changes in peri-articular and subchondral bone. Osteoarthritis is 
the most common type of arthritis. Multiple factors are involved in 
the pathogenesis of OA, including mechanical influences, the effects 
of aging on cartilage matrix composition and structure, and genetic 
factors. Since the initial stages of OA involve increased cell 
proliferation and synthesis of matrix proteins, proteinases, growth 
factors, cytokines, and other inflammatory mediators by 
chondrocytes, research has focused on the chondrocyte as the 
cellular mediator of OA pathogenesis. The aims of this study was to 
analyze the patterns of drug used based on clinical data and to 
identify the drug related problems in osteoarthritis patients. This 
research was observational study by using the retrospective method 
and the descriptive analysis. The sample was entire patients in 
Orthopaedic Clinic of Outpatient Installation at RSUD Dr. Soetomo 
Surabaya with osteoarthritis diagnosed with or without underlying 
disease or complication. The sample period was from January 2015 
until January 2016 that fulfilling inclusion criteria          (N = 38). 
Patient’s profile were 57.9 % females and 42.1 % males. The results 
showed that the patterns of drug used in osteoarthritis patients were 
analgetics and inflammatory drugs including meloxicam (86.8%), 
sodium diclofenac (76.3%), piroxicam (23.7%), mefenamic acid 
(7.9%), ibuprofen (2.6%) and Aspirin (2.6%). Adjuvant analgetics 
were diazepam (34.2%) and alprazolam (2.6%). While DMOADs 
was glukosamin applied by 60.5 % patients. Corticosteroids that has 
been used are methyl prednisolone (13.1%), prednisolone (2.6%) and 
triamsinolone (2.6%). Therapy for prevention and treatment of GIT 
disorders were antacid (13.1%), ranitidine (13.1%), cimetidine 
(2.6%) dan metoclopramide (2.6%). The drug related problems 
(DRPs) mostly occurred was GIT disorders (34.2%). 
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